Juvenile Arthritis Research

Introducing Juvenile Arthritis Research - searching for a cure for JIA
Juvenile Arthritis Research (JAR) is a non-profit project researching a cure for Juvenile Idiopathic Arthritis, a crippling autoimmune disorder that affects 1 in every 1,000 children under the age of 16.
In January 2018, Richard Beesley started working full-time to find a cure for Juvenile Idiopathic Arthritis (JIA), operating under the working title of ‘Juvenile Arthritis Research’ (JAR). Richard has a background in medical research at the Institute of Child Health (University College London), and clinical research at the Horder Centre (an independent orthopaedic hospital). With eighteen years’ experience of project management, analysis, and data collation in a range of sectors, Richard launched JAR.

Having seen first-hand the damage that Juvenile Idiopathic Arthritis causes (his daughter, Trinity, was diagnosed when she was two years old) he was motivated to make a difference. Whilst current treatment options are a vast improvement on those available previously (Richard’s wife had JIA from the age of 10 and, with only pain relief available as treatment, suffered permanent damage resulting in a hip replacement recently), children with JIA still require regular injections, tests and therapies. With a vision for doing things better and the skills and experience to collate information from a wide range of sources, he formed Juvenile Arthritis Research with the aim of finding the cure for JIA.


Support us

Support us

Secure online giving at give.net